CTOs on the Move

Endotronix

www.endotronix.com

 
Endotronix, a digital health medtech company, is developing an integrated platform to provide comprehensive, reimbursable health management tools for patients suffering from advanced heart failure. The Cordella™ Heart Failure System includes a cloud-based disease-management system and a breakthrough implantable wireless pulmonary artery pressure sensor. The seamlessly integrated system enables proactive management and early detection of worsening heart failure, which promotes ongoing therapeutic interventions to improve quality of life, reduce hospital readmissions, and lower care costs.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.endotronix.com
  • 1005 Internationale Parkway Suite 104
    Woodridge, IL USA 60517
  • Phone: 309.282.3758

Executives

Name Title Contact Details

Funding

Endotronix raised $32M on 07/16/2016
Endotronix raised $37.1M on 02/26/2018
Endotronix raised $45M on 09/14/2018

Similar Companies

Allied Medical Services

Allied Medical Services is a Tinton Falls, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lakeshore Biomaterials Inc

Lakeshore Biomaterials Inc is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hancock Jaffe Laboratories

Hancock Jaffe Laboratories, Inc. is a medical device company based out of Irvine, California, United States.

HeartFlow

HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide. Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlow`s footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics. We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care.

Revolution Enterprises

Revolution Cannabis is committed to producing the cleanest, most reliable and efficacious medical cannabis products. Our team is comprised of passionate cannabis cultivation, public health, and research professionals united by a desire to cultivate health and happiness through the science of cannabis. Revolution`s core values permeate every facet of operations spanning cultivation, breeding, production, packaging, labeling, community outreach, and more.